Alberta, CA

British Columbia, CA

Manitoba, CA

New Brunswick, CA

Newfoundland and Labrador, CA

Nova Scotia, CA

Northwest Territories, CA

Nunavut, CA

Ontario, CA

Prince Edward Island, CA

Quebec, CA

Saskatchewan, CA

Yukon, CA

Pharmaceutical and medicinal products

United Arab Emirates (the)

Afghanistan

Antigua and Barbuda

Albania

Angola

Argentina

Austria

Australia

Barbados

Bangladesh

Belgium

Burkina Faso

Bulgaria

Bahrain

Burundi

Benin

Bolivia, Plurinational State of

Brazil

Bahamas

Bhutan

Belize

Canada

Central African Republic

Congo

Switzerland

Côte d'Ivoire

Chile

Cameroon

China

Colombia

Costa Rica

Cyprus

Czechia

Germany

Denmark

Dominica

Dominican Republic

Algeria

Ecuador

Estonia

Egypt

Spain

Ethiopia

Finland

Fiji

France

Gabon

United Kingdom

Grenada

Gambia

Guinea

Equatorial Guinea

Greece

Guatemala

Guinea-Bissau

Hong Kong

Honduras

Croatia

Haiti

Hungary

Indonesia

Ireland

Israel

India

Iraq

Iran, Islamic Republic of

Iceland

Italy

Jamaica

Jordan

Japan

Kenya

Cambodia

Kiribati

Saint Kitts and Nevis

Korea, Republic of

Kuwait

Kazakhstan

Lao People's Democratic Republic

Lebanon

Saint Lucia

Sri Lanka

Lesotho

Lithuania

Luxembourg

Latvia

Morocco

Moldova, Republic of

North Macedonia

Mali

Myanmar

Mongolia

Malta

Mauritius

Maldives

Malawi

Mexico

Malaysia

Namibia

Niger

Dental laboratories

Home health care services

Nursing and community care facilities

Emission intensity of the supply chain per Canadian dollar spent on: Pharmaceutical and medicinal products. Retrieved from the OpenIO-Canada v2.11 model which is a Canadian Environmentally Extended Input-Output (EEIO) model. The emission factor is provided in purchaser price including taxes retail margins and distribution costs. Endogenization is not included meaning the emission factor does not also accounts for capital goods.

Emission intensity of the supply chain per Canadian dollar spent on: Pharmaceutical and medicinal products. Retrieved from the OpenIO-Canada v2.11 model which is a Canadian Environmentally Extended Input-Output (EEIO) model. The emission factor is provided in purchaser price including taxes retail margins and distribution costs. Endogenization is included meaning the emission factor also accounts for capital goods.

Emission intensity of the supply chain per Canadian dollar spent on: pharmaceutical and medicinal products. Retrieved from the OpenIO-Canada v2.9 model which is a Canadian Environmentally Extended Input-Output (EEIO) model. The emission factor is provided in purchaser price including taxes retail margins and distribution costs. Endogenization is not included meaning the emission factor does not account for capital goods.

Emission intensity of the supply chain per Canadian dollar spent on: pharmaceutical and medicinal products. Retrieved from the OpenIO-Canada v2.9 model which is a Canadian Environmentally Extended Input-Output (EEIO) model. The emission factor is provided in purchaser price including taxes retail margins and distribution costs. Endogenization is included meaning the emission factor also accounts for capital goods.

Property	Value
Name	Pharmaceutical and medicinal products
Sector	Health and Social Care
Category	Health Care
Source	OpenIO-Canada
Region	Alberta, CA (CA-AB), British Columbia, CA (CA-BC), Manitoba, CA (CA-MB), New Brunswick, CA (CA-NB), Newfoundland and Labrador, CA (CA-NL), Nova Scotia, CA (CA-NS), Northwest Territories, CA (CA-NT), Nunavut, CA (CA-NU), Ontario, CA (CA-ON), Prince Edward Island, CA (CA-PE) View all 13 regions
Unit Type	Money
Year	2022 to 2018
LCA Activity	cradle_to_gate, cradle_to_gate_inc_capital_endogenization

Pharmaceutical and medicinal products

Activity summary

API Reference

Interested in licensing this data?

Related factors

Health Care Emission Factors

Dental laboratories

Home health care services

Nursing and community care facilities